BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12682824)

  • 1. Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications.
    Caimi G; Montana M; Ferrara F; Porretto F; Musso M; Canino B; Lo Presti R
    Acta Diabetol; 2003 Mar; 40(1):14-9. PubMed ID: 12682824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte integrin profile in diabetes mellitus.
    Caimi G; Montana M; Citarrella R; Porretto F; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 2002; 27(2):83-9. PubMed ID: 12237478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease.
    Lo Presti R; Canino B; Montana M; Ferrara F; Carollo C; Porretto F; Caimi G
    Clin Hemorheol Microcirc; 2004; 30(1):53-60. PubMed ID: 14967884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leukocyte integrins in chronic renal failure.
    Caimi G; Montana M; Carollo C; Porretto F; Vaccaro F; Canino B; Lo Presti R
    Clin Hemorheol Microcirc; 2005; 32(1):43-9. PubMed ID: 15665425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep venous thrombosis: behaviour of the polymorphonuclear leukocyte integrin pattern at baseline and after in vitro activation.
    Caimi G; Tozzi Ciancarelli MG; Ferrara F; Montana M; Calandrino V; Canino B; Lo Presti R
    Clin Hemorheol Microcirc; 2005; 33(1):11-7. PubMed ID: 16037628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
    Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
    Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
    Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte integrins before and after activation in acute ischaemic stroke.
    Caimi G; Canino B; Ferrara F; Montana M; Musso M; Porretto F; Carollo C; Catania A; Lo Presti R
    J Neurol Sci; 2001 May; 186(1-2):23-6. PubMed ID: 11412867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of beta2-integrin on monocytes and blood polymorphonuclear leukocytes in the periparturient period in dairy cows.
    Diez-Fraile A; Duchateau L; Meyer E; Burvenich C
    Can J Vet Res; 2003 Jul; 67(3):235-8. PubMed ID: 12889733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Natural Killer cell cytotoxicity by a CD18 integrin-activating antibody.
    Sadhu C; Harris EA; Staunton DE
    Biochem Biophys Res Commun; 2007 Jul; 358(3):938-41. PubMed ID: 17512497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
    Caimi G; Lo Presti R; Montana M; Ferrara F; Ventimiglia G; Meli F; Catania A; Canino B
    Horm Metab Res; 1998 Feb; 30(2):72-6. PubMed ID: 9543687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased monocyte alphaL, alphaM and beta2 integrin subunits in diabetes mellitus.
    Kostidou E; Koliakos G; Kaloyianni M
    Clin Biochem; 2009 May; 42(7-8):634-40. PubMed ID: 19135988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in Type II diabetes.
    Advani A; Marshall SM; Thomas TH
    Diabetologia; 2002 May; 45(5):719-27. PubMed ID: 12107753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of polymorphonuclear leukocytes in development vascular complications in diabetes].
    Mastej K; Adamiec R
    Pol Merkur Lekarski; 2006 Jan; 20(115):36-40. PubMed ID: 16617732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-dependent proteolytic degradation of polymorphonuclear CD11b.
    Davey PC; Zuzel M; Kamiguti AS; Hunt JA; Aziz KA
    Br J Haematol; 2000 Dec; 111(3):934-42. PubMed ID: 11122158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing neutrophil F-actin corrects CD11b exposure in Type 2 diabetes.
    Advani A; Marshall SM; Thomas TH
    Eur J Clin Invest; 2004 May; 34(5):358-64. PubMed ID: 15147333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphonuclear leukocyte integrins in deep venous thrombosis.
    Caimi G; Canino B; Ferrara F; Montana M; Lo Presti R
    Clin Appl Thromb Hemost; 2005 Jan; 11(1):95-7. PubMed ID: 15678279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.
    Caimi G; Presti RL; Carollo C; Musso M; Porretto F; Canino B; Catania A; Cerasola G
    Hypertension; 2000 Nov; 36(5):813-7. PubMed ID: 11082148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANTES and eotaxin enhance CD11b and CD18 expression on eosinophils from allergic patients with eosinophilia in the application of whole Blood flow cytometry analysis.
    Chiba T; Kamada Y; Saito N; Oyamada H; Ueki S; Kobayashi Y; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():12-6. PubMed ID: 15947479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.